WHO and EU Step Up Ebola Response as Bundibugyo Outbreak Strains DRC and Uganda

The European Commission has put an additional 15 million euro into the Ebola response in the Democratic Republic of the Congo and Uganda, and the World Health Organisation says it is adding its own support in both countries. The two announcements point to an outbreak that is far from contained, and one involving a strain of the virus with no approved tools to fight it.

The virus is the Bundibugyo strain. Unlike the better-known Zaire strain, Bundibugyo has no licensed vaccine and no approved targeted treatment. That leaves health officials leaning on the older methods of outbreak control: rapid diagnosis, isolating patients, tracing their contacts, burying the dead safely, and running community awareness campaigns. Earlier Bundibugyo outbreaks have had case fatality rates of 30 to 50 percent, depending on how quickly patients got supportive care.

The WHO says its additional support covers contact tracing, surveillance, clinical preparedness, delivery of supplies, and community outreach. The EU money is meant for response and preparedness work in the affected countries. Dr Hans Henri P. Kluge, WHO's Regional Director for Europe, said viruses do not stop at borders, and neither does the partnership. He pointed to the EU's work with WHO on rapid response, sharing expertise, surveillance, genomic sequencing, vaccine research and fast delivery of supplies as an example of effective multilateral action. He also thanked the EU for its solidarity with people in the DRC and Uganda, calling the effort a demonstration of what Europe and Africa can do as genuine partners.

The outbreak is centred in eastern DRC, in the provinces of Ituri, North Kivu and South Kivu. WHO data show hundreds of confirmed cases and dozens of deaths, with more suspected cases still being investigated. Uganda has confirmed infections linked to cross-border transmission from the DRC. These areas are major trade and migration corridors, so people move constantly between communities and across the border. If surveillance misses infections, the virus can travel with them.

Detection has been a weak point. Ebola begins with fever, fatigue, headache, muscle pain and weakness, symptoms easily mistaken for malaria, typhoid or other common tropical illnesses, so laboratory testing is needed to tell them apart. The outbreak reportedly went unnoticed for several weeks before it was formally identified, which let transmission continue in the meantime.

Security makes everything harder. Armed conflict, displacement and weak health infrastructure in parts of eastern DRC complicate contact tracing and the work of building trust with local people. WHO officials have repeatedly warned that control efforts become much harder when health workers cannot safely reach affected communities. Experts add that past Ebola outbreaks showed how misinformation, fear and mistrust can undermine containment and keep transmission going.

WHO has designated the outbreak a Public Health Emergency of International Concern, citing its potential to cross borders and the need for coordinated action, even though the risk of widespread transmission outside the affected regions is described as low. The EU, the World Bank, Africa CDC and other partners have mobilised resources to support preparedness and frontline health workers.

What to watch is whether surveillance and community trust improve fast enough to stop the spread across borders, given how long the outbreak ran undetected.